English (United Kingdom)

https://curated-unify.zendy.io/wp-json/zendy-region/v1/featured_content/oa?rat=en

https://curated-unify.zendy.io/wp-json/zendy-region/v1/highlighted_journal/

Global: Zendy Plus annual

Presents the access of premium content as premium feature

Premium Content

Presents the keyphrase highlighting as premium feature

Keyphrase Highlighting

Presents the summarisation as premium feature

Summarisation

Insights

Presents the pdf analysis as premium feature

PDF Analysis

Presents the zaia usage as premium feature

ZAIA

Global: Zendy Tools annual

Global: Zendy Free Plan

Global: Zendy Tools monthly

Global: Zendy Plus monthly

The report of the CINP Task Force ‘Antidepressant medications and other treatments of depressive disorders’ (CINP Task Force, 2007) represents a scholarly and comprehensive review on the huge literature on antidepressants. As such, it is within the burgeoning modern tradition of evidence-based medicine. However, as a CINP report several points mentioned in the review could use additional emphasis.(1) The CINP is an organization promoting interaction between research psychopharmacologists, clinical psychopharmacologists and the pharmaceutical industry. A review done by a strict computer search, evidence-based approach can be biased by the fact that pharmaceutical company funding favours controlled trials of new patented compounds and that alternative and non-patented treatments often have small numbers and inferior methodology (Turner et al., 2008). The CINP is committed to attempting to correct this bias by searching out promising new treatments of depression anywhere in the world, including unpatented natural remedies that may have potential such as herbal remedies, Hypericum , inositol, omega-3, …

Comment on: ‘Antidepressant medications and other treatments of depressive disorders: a CINP Task Force report based on a review of evidence’